This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007 Sep;12(7):939-49.

doi: 10.1007/s00775-007-0265-3. Epub 2007 Jul 21.

Multimodal MRI contrast agents

Luca Frullano¹, Thomas J Meade

Affiliations

Affiliation

¹ Department of Chemistry, Biochemistry and Molecular and Cell Biology, Neurobiology and Physiology, Radiology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208, USA.

PMID: 17659368
DOI: 10.1007/s00775-007-0265-3

Review

Multimodal MRI contrast agents

Luca Frullano et al. J Biol Inorg Chem. 2007 Sep.

. 2007 Sep;12(7):939-49.

doi: 10.1007/s00775-007-0265-3. Epub 2007 Jul 21.

Authors

Luca Frullano¹, Thomas J Meade

Affiliation

¹ Department of Chemistry, Biochemistry and Molecular and Cell Biology, Neurobiology and Physiology, Radiology, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208, USA.

PMID: 17659368
DOI: 10.1007/s00775-007-0265-3

No abstract available

PubMed Disclaimer

Similar articles

A gadolinium complex confined in silica nanoparticles as a highly efficient T1/T2 MRI contrast agent.
Wartenberg N, Fries P, Raccurt O, Guillermo A, Imbert D, Mazzanti M. Wartenberg N, et al. Chemistry. 2013 May 27;19(22):6980-3. doi: 10.1002/chem.201300635. Epub 2013 Apr 18. Chemistry. 2013. PMID: 23606305 No abstract available.
Contrast agents for MRI.
Shokrollahi H. Shokrollahi H. Mater Sci Eng C Mater Biol Appl. 2013 Dec 1;33(8):4485-97. doi: 10.1016/j.msec.2013.07.012. Epub 2013 Jul 18. Mater Sci Eng C Mater Biol Appl. 2013. PMID: 24094150 Review.
Towards the rational design of magnetic resonance imaging contrast agents: isolation of the two coordination isomers of lanthanide DOTA-type complexes.
Woods M, Kovacs Z, Zhang S, Sherry AD. Woods M, et al. Angew Chem Int Ed Engl. 2003;42(47):5889-92. doi: 10.1002/anie.200352234. Angew Chem Int Ed Engl. 2003. PMID: 14673928 No abstract available.
PARACEST agents: modulating MRI contrast via water proton exchange.
Zhang S, Merritt M, Woessner DE, Lenkinski RE, Sherry AD. Zhang S, et al. Acc Chem Res. 2003 Oct;36(10):783-90. doi: 10.1021/ar020228m. Acc Chem Res. 2003. PMID: 14567712 Review.
Lanthanides in magnetic resonance imaging.
Bottrill M, Kwok L, Long NJ. Bottrill M, et al. Chem Soc Rev. 2006 Jun;35(6):557-71. doi: 10.1039/b516376p. Epub 2006 May 2. Chem Soc Rev. 2006. PMID: 16729149 Review.

See all similar articles

Cited by

Synthesis and evaluation of a targeted nanoglobular dual-modal imaging agent for MR imaging and image-guided surgery of prostate cancer.
Tan M, Ye Z, Lindner D, Brady-Kalnay SM, Lu ZR. Tan M, et al. Pharm Res. 2014 Jun;31(6):1469-76. doi: 10.1007/s11095-013-1008-5. Epub 2013 Mar 8. Pharm Res. 2014. PMID: 23471641 Free PMC article.
Magnetic nanoparticles in MR imaging and drug delivery.
Sun C, Lee JSH, Zhang M. Sun C, et al. Adv Drug Deliv Rev. 2008 Aug 17;60(11):1252-1265. doi: 10.1016/j.addr.2008.03.018. Epub 2008 Apr 10. Adv Drug Deliv Rev. 2008. PMID: 18558452 Free PMC article. Review.
Lanthanide(III) complexes of rhodamine-DO3A conjugates as agents for dual-modal imaging.
Rivas C, Stasiuk GJ, Gallo J, Minuzzi F, Rutter GA, Long NJ. Rivas C, et al. Inorg Chem. 2013 Dec 16;52(24):14284-93. doi: 10.1021/ic402233g. Epub 2013 Dec 4. Inorg Chem. 2013. PMID: 24304423 Free PMC article.
Near infrared-fluorescent and magnetic resonance imaging molecular probe with high T1 relaxivity for in vivo multimodal imaging.
Guo K, Berezin MY, Zheng J, Akers W, Lin F, Teng B, Vasalatiy O, Gandjbakhche A, Griffiths GL, Achilefu S. Guo K, et al. Chem Commun (Camb). 2010 Jun 7;46(21):3705-7. doi: 10.1039/c000536c. Epub 2010 Apr 13. Chem Commun (Camb). 2010. PMID: 20390151 Free PMC article.
Theranostic Magnetic Nanostructures (MNS) for Cancer.
Nandwana V, De M, Chu S, Jaiswal M, Rotz M, Meade TJ, Dravid VP. Nandwana V, et al. Cancer Treat Res. 2015;166:51-83. doi: 10.1007/978-3-319-16555-4_3. Cancer Treat Res. 2015. PMID: 25895864 Free PMC article. Review.

See all "Cited by" articles

References

1. Bioconjug Chem. 2002 Mar-Apr;13(2):264-8 - PubMed
1. Curr Pharm Biotechnol. 2004 Dec;5(6):519-28 - PubMed
1. Cancer Res. 2002 Nov 15;62(22):6731-9 - PubMed
1. Acc Chem Res. 2003 Oct;36(10):783-90 - PubMed
1. Neuroimage. 2004 Jan;21(1):311-7 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

R01 EB005866/EB/NIBIB NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information